natgillin/translations-raw huggingface dataset:
SE - Швеция Eli Lilly Sweden AB Box 721 
Eli Lilly Sweden AB Box 721
PT - Португалия Merck, S.A. Rua Alfredo da Silva, 3 C, 1300-040 
Merck, S.A. Rua Alfredo da Silva, 3 C, 1300-040
- Франция SANOFI AVENTIS France 1-13, boulevard Romain Rolland 
FR - France SANOFI AVENTIS France 1-13, boulevard Romain Rolland
DK 2750 Ballerup 
DK 2750 Ballerup Denmark
- Финландия Pfizer Oy, Tietokuja 4, 00330 Helsinki, 
FI - Finland Pfizer Oy, Tietokuja 4, 00330 Helsinki, Finland
PFIZER SA Bld de la Plaine,17 1050 Brussels 
PFIZER SA Bld de la Plaine,17 1050 Brussels Belgium
Rua Cesário Verde, nº 5, 4º Piso, Linda-a-Pastora, 2790-326 Queijas, 
Rua Cesário Verde, nº 5, 4º Piso, Linda-a-Pastora, 2790-326 Queijas, Portugal
ELI LILLY ČR, s.r.o., Pobřežní 12, 180 00 Praha 8, Чешка република 
ELI LILLY ČR, s.r.o., Pobřežní 12, 180 00 Praha 8, Czech Republic
Ferring Lægemidler A/S, Kay Fiskers Plads 11, DK-2300 Købenahvn S, 
Ferring Lægemidler A/S, Kay Fiskers Plads 11, DK2300 Købenahvn S, Denmark
NOVO NORDISK HELLAS Panagouli 80 & Agias Triadas 65, Agia Paraskevi 15343, 
EL - Greece NOVO NORDISK HELLAS Panagouli 80 & Agias Triadas 65, Agia Paraskevi
Ferring BV Polariavenue 132 2132JX 
Ferring BV Polariavenue 132 2132JX HoofddorpNederland
- Исландия Eli Lilly Danmark Nybrovej 110 
IS - Iceland Eli Lilly Danmark Nybrovej 110
BAKER ITALIA SpA VIA DI PORTA PINCIANA, 6 00187 
IT - Italy BAKER ITALIA SpA VIA DI PORTA PINCIANA, 6 00187 ROMA
Novo Nordisk Limited, Broadfield Park, Brighton Road, Crawley, West Sussex RH11 9RT, 
Novo Nordisk Limited, Broadfield Park, Brighton Road, Crawley, West Sussex RH11 9RT, UK
Pfizer ApS, Lautrupvang 8, DK-2750 Ballerup, 
Pfizer ApS, Lautrupvang 8, DK-2750 Ballerup, Denmark
NO - Норвегия Pfizer AS, Postboks 3, 1324 Lysaker, Норвегия 
Pfizer AS, Postboks 3, 1324 Lysaker, Norway
- Португалия Ferring PortuguesaProdutos Farmacêuticos, Sociedade Unipessoal, Lda. 
Ferring PortuguesaProdutos Farmacêuticos, Sociedade Unipessoal, Lda.
- Словения Eli Lilly farmacevtska družba, d.o.o., Brnčičeva 41g, 1231 Ljubljana 
Eli Lilly farmacevtska družba, d.o.o., Brnčičeva 41g, 1231 LjubljanaČrnuče, Slovenia
1138 Budapest 
1138 Budapest Hungary
1113 Budapest 
1113 Budapest Hungary
- Финландия Eli Lilly Finland Oy Ab, Rajatorpantie 41 C, PL 16, 01641 Vantaa, 
FI - Finland Eli Lilly Finland Oy Ab, Rajatorpantie 41 C, PL 16, 01641 Vantaa, Finland
DE - Германия Lilly Deutschland GmbH Teichweg 3 
Lilly Deutschland GmbH Teichweg 3
ROMA, Италия 
Roma, Italy
NO - Норвегия Elly Lilly Norge AS, Grensevien 99, 0663 
Elly Lilly Norge AS, Grensevien 99, 0663 Oslo, Norway
Ferring Phamraceuticals Limited, The Courtyard, Waterside Drive, Langley, Berkshire SL3 
Ferring Phamraceuticals Limited, The Courtyard, Waterside Drive, Langley, Berkshire SL3 6EZ, UK
Bagsvaerd, Дания 
Bagsvaerd, Denmark
DE - Германия Merck Serono GmbH Alsfelder Str. 17 
Merck Serono GmbH Alsfelder Str. 17
ELI LILLY BENELUX SA Rue de l'Etuve 52/1 1000 Brussels 
ELI LILLY BENELUX SA Rue de l'Etuve 52/1 1000 Brussels Belgium
Pfizer Health AB, Vetenskapsvagen 10,SE191 90 Sollentuna, 
LV - Latvia Pfizer Health AB, Vetenskapsvagen 10,SE191 90 Sollentuna, Sweden
FERRING NV Hopmarkt 9 b3 9300 Aalst 
FERRING NV Hopmarkt 9 b3 9300 Aalst Belgium
DE - Германия Pharmacia GmbH Linkstr. 
Pharmacia GmbH Linkstr.
- Испания PFIZER, S.A.Avda. 
ES - Spain PFIZER, S.A.Avda.
Hauptstraße 1 
Floridsdorfer Hauptstraße 1
- Финландия Ferring Lääkkeet Oy, Piispansilta 11 A, PL 23, 02241 Espoo, 
FI - Finland Ferring Lääkkeet Oy, Piispansilta 11 A, PL 23, 02241 Espoo, Finland
NO - Норвегия Ferring Legemidler AS, Postboks 4445, 0403 
Ferring Legemidler AS, Postboks 4445, 0403 Oslo, Norway
FR - Франция PFIZER HOLDING France 23-25, avenue du 
FR - France PFIZER HOLDING France 23-25, avenue du Docteur Lannelongue
PT - Португалия Lilly-Portugal, Produtos Farmacêuticos, Lda. 
Lilly-Portugal, Produtos Farmacêuticos, Lda.
Pfizer Italia S.r.l. 
IT - Italy Pfizer Italia S.r.l.
Merck Serono S.p.A., Via Casilina 125, I-00176 
LV - Latvia Merck Serono S.p.A., Via Casilina 125, I-00176
FERRING HELLAS S.A. GKYZI 3, MAROUSI 15125, Гърция 
EL - Greece FERRING HELLAS S.A. GKYZI 3, MAROUSI 15125
- Финландия Merck Oy, Pihatörmä 1 C, 02240 Espoo, 
FI - Finland Merck Oy, Pihatörmä 1 C, 02240 Espoo, Finland
3991 RA HOUTEN 
3991 RA HOUTEN Nederland
José - Piso 1, 2780-730 Paço d' Arcos, 
Quinta da FonteEdifício D. José - Piso 1, 2780-730 Paço d' Arcos, Portugal
AT - Австрия Novo Nordisk Pharma GmbH 
AT - Austria Novo Nordisk Pharma GmbH
D-24109 Kiel, Германия hGH-Ferring 12 (4 mg) 
D-24109 Kiel hGH-Ferring 12 (4 mg) 4.32 mg
Wienerbergstr. 
Brucknerstr.
00176 Roma, Италия 
00176 Roma Italy
Pfizer Hellas S.A. 234, Messoghion Ave., Neo Psychiko 15451, Athens, 
EL - Greece Pfizer Hellas S.A. Messoghion Ave., Neo Psychiko 15451, Athens, Greece
BG - България Pfizer Enterprises SARL, Rond-point du Kirchberg, 51, Avenue J.F.Kennedy, L-1855 Luxembourg, 
Pfizer Enterprises SARL, Rond-point du Kirchberg, 51, Avenue J.F.Kennedy, L1855 Luxembourg, Luxembourg
HU - Унгария Merck Kft. 
Merck Kft.
DK-2880 Bagsværd 
DK-2880 Bagsværd Denmark
Serono Limted, Bedfont Cross, Stanwell Road, Feltham, Middlesex TW14 8NX, 
Serono Limted, Bedfont Cross, Stanwell Road, Feltham, Middlesex TW14 8NX, UK
ZOMACTON 4 mg (12 UI) 
ZOMACTON 4 mg (12UI) 4 mg (12UI)
FARMASERV LILLY AEBE 15TH Km NATIONAL HIGHWAY ATHENSLAMIA 
EL - Greece FARMASERV LILLY AEBE 15TH Km NATIONAL HIGHWAY ATHENS-LAMIA KIFISSIA 14564, P.O.
ET - Естония Merck Serono S.p.A. 
ET - Estonia Merck Serono S.p.A.
TW14 8NX, England, 
8NX, England
Merck A.E. Hellas Kifisias Avenue 41-45 (Building B) Marousi 15123 
EL - Greece Merck A.E. Hellas Kifisias Avenue 41-45 (Building B)
8 mg (24 NE) /1,5 ml 
8mg (24 NE) /1,5ml parenteral use
NO - Норвегия Merck AB, 195 87 Stockholm, Швеция 
Merck AB, 195 87 Stockholm, Sweden
SAIZEN (CLICK.EASY) 8 mg (5,83 mg/ml) 
SAIZEN (CLICK.EASY) 8 mg (5,83 mgml)
IE - Ирландия Pharmacia Laboratories Limited, Ramsgate Road, Sandwich, Kent, CT13 
IE - Ireland Pharmacia Laboratories Limited, Ramsgate Road, Sandwich, Kent, CT13 9NJ, United Kingdom
Eli Lilly Holdings Limited, Lilly House Priestley Road Basingstoke Hampshire RG24 9NL, 
Eli Lilly Holdings Limited, Lilly House Priestley Road Basingstoke Hampshire RG24 9NL, United Kingdom
Pfizer Limited, Ramsgate Road, Sandwich, Kent, CT13 9NJ, 
Pfizer Limited, Ramsgate Road, Sandwich, Kent, CT13 9NJ, United Kingdom
6EZ, Великобритания 
UK - United Kingdom
DE - Германия Novo Nordisk Pharma GmbH 
Novo Nordisk Pharma GmbH
SE - Швеция Novo Nordisk A/S Novo Allé 
Novo Nordisk A/S Novo Allé
Eli Lilly & Company Limited, Lilly House, Priestly Road, Basingstoke, Hampshire RG24 9NL, 
Eli Lilly & Company Limited, Lilly House, Priestly Road, Basingstoke, Hampshire RG24 9NL, UK
DK-2880 Bagsvaerd 
DK-2880 Bagsvaerd Denmark
Industria Farmaceutica Serono S.p. A Via Casilina, 125, Rome, 00176, Италия 
Via Casilina, 125, Rome, 00176, Italy
Eli Lilly Danmark A/S, Nybrovej 110, DK-2800 Kongens Lyngby, Дания 
Eli Lilly Danmark A/S, Nybrovej 110, DK-2800
- Словения NovoNordis A/S, Novo Alle, Basvaerd, Дания 
NovoNordis A/S, Novo Alle, Basvaerd, DK
- Ирландия Serono Limited, Bedfont Cross, Stanwell Road, Feltham, Middlesex, 
IE - Ireland Serono Limited, Bedfont Cross, Stanwell Road, Feltham, Middlesex, TW14
SE - Швеция E. Merck AB 195 87 Stockholm 
E. Merck AB 195 87 Stockholm Sweden
ZOMACTON 10 mg/ml, poudre et solvant pour solution injectable en seringue préremplie 
ZOMACTON 10 mg/ml, poudre et solvant pour solution injectable en seringue préremplie subcutaneous
Белгия 
BEBelgium
FERRING SpA VIA SENIGALLIA, 18/2 20161 MILANO, Италия 
IT - Italy FERRING SpA VIA SENIGALLIA, 18/2
Инжекция 
Injektionslösung
Pfizer Europe MA EEIG., Sandwich, Kent, CT13, 
Pfizer Europe MA EEIG., Sandwich, Kent, CT13, 9NJ, United Kingdom
- Исландия Merck AB SE-195 87 Stockholm 
IS - Iceland Merck AB SE-195 87 Stockholm Sweden
AT - Австрия Ferring Arzneimittel GmbH 
AT - Austria Ferring Arzneimittel GmbH Wienerbergstr.
Magna Drive, Magna Business Park, Citywest Road, Dublin 24, 
IE - Ireland Ferring Ireland Ltd., United Drug House, Magna Drive, Magna Business Park, Citywest Road, Dublin 24, Ireland
SAIZEN CLICKEASY 8 mg, poudre et solvant pour solution injectable 
SAIZEN CLICKEASY 8 mg, poudre et solvant pour solution injectable subcutaneous
SAIZEN 8 mg, poudre et solvant pour solution injectable 
SAIZEN 8 mg, poudre et solvant pour solution injectable subcutaneous
DE - Германия Ferring GmbH Wittland 11 
ET - Estonia Ferring GmbH Wittland 11
- Естония Ferring GmbH Wittland 11 
Ferring GmbH Wittland 11
HU - Унгария Ferring Magyarország Kft. 
Ferring Magyarország Kft. Váci út 140.
Нидерландия 
NLNetherlands
ELI LILLY ITALIA SpA VIA GRAMSCI, 731/733 SESTO FIORENTINO 50019 FIRENZE, Италия 
IT - Italy ELI LILLY ITALIA SpA VIA GRAMSCI, 731/733
ZOMACTON 4 mg, poudre et solvant pour solution injectable en multidose 
ZOMACTON 4 mg, poudre et solvant pour solution injectable en multidose subcutaneous
30 rue de Valmy 
30 rue de Valmy 92800 Puteaux-France
Zomacton 10 mg powder and solvent for solution for injection in pre-filled syringe 
Zomacton 10 mg powder and solvent for solution for injection in pre-filled syringe powder and solvent for solution for injection in pre-filled syringe
Pfizer Europe MA EEIG Ramsgate Road, CT13 9 NJ, Sandwich, Kent, 
PL - Poland Pfizer Europe MA EEIG Ramsgate Road, CT13 9 NJ, Sandwich, Kent, United Kingdom
MAXOMAT 1,3 mg, poudre et solvant pour solution injectable 
MAXOMAT 1,3 mg, poudre et solvant pour solution injectable subcutaneous
ZOMACTON 4 mg polvo y disolvente en jeringa precargada para solución inyectable 
ZOMACTON 4 mg polvo y disolvente en jeringa precargada para solución inyectable powder for solution Subcutaneous use
1123 Budapest 
Alkotás u. 53 1123 Budapest Hungary
click easy 8 mg 8 mg 
Saizen click easy 8 mg 8 mg s.c.
Humatrope 24 mg prašek in vehikel za raztopino 
Humatrope 24 mg prašek in vehikel za raztopino in injiciranje
ZOMACTON 10 mg/ ml polvo y disolvente en jeringa precargada para solución inyectable 
ZOMACTON 10 mg/ ml polvo y disolvente en jeringa precargada para solución inyectable powder for solution Subcutaneous use
HUMATROPE 72 NE (24 mg) injekció patronban 
HUMATROPE 72 NE (24 mg) injekció patronban powder and solvent for injection
SAIZEN 8 mg click.easy polvo y disolvente para solución inyectable 
SAIZEN 8 mg click.easy polvo y disolvente para solución inyectable powder for solution Subcutaneous use
HUMATROPE 18 NE (6 mg) injekció patronban 
HUMATROPE 18 NE (6 mg) injekció patronban powder and solvent for injection
UMATROPE 24 mg/3 ml, poudre et solvant pour solution injectable 
UMATROPE 24 mg/3 ml, poudre et solvant pour solution injectable subcutaneous
SK - Словакия Merck Serono S.p.A. 
IT - Italy Merck Serono S.p.A.
SAIZEN 3,33 mg, poudre et solvant pour solution injectable 
SAIZEN 3,33 mg, poudre et solvant pour solution injectable subcutaneous
Подкожно приложение, интрамускулно приложение 
Subcutaneous use; Intramuscular use
Humatrope 6 mg prašek in vehikel za raztopino 
Humatrope 6 mg prašek in vehikel za raztopino in injiciranje
UMATROPE 6 mg/3 ml, poudre et solvant pour solution injectable 
UMATROPE 6 mg/3 ml, poudre et solvant pour solution injectable subcutaneous
2795-240 Linda-a-Velha, 
Rua Alexandre HerculanoEdifício 1, Piso 6, 2795-240 Linda-a-Velha, Portugal
Bedfont Cross, Stanwell Road 
MT - Malta Serono Ltd Bedfont Cross, Stanwell Road
Humatrope 12 mg For Injection 
Humatrope 12mg For Injection powder for injection subcutaneous use
SAIZEN 1,33 mg, poudre et solvant pour solution injectable 
SAIZEN 1,33 mg, poudre et solvant pour solution injectable subcutaneous
15 mg/1,5 ml oldatos injekció 
15MG/1.5ML SOLUTION FOR INJECTION
Novo Nordisk A/S Novo Alle, Bagsvaerd, DK-2880, Дания 
PL - Poland Novo Nordisk A/S Novo Alle, Bagsvaerd, DK2880, Denmark
UMATROPE 12 mg/3 ml, poudre et solvant pour solution injectable 
UMATROPE 12 mg/3 ml, poudre et solvant pour solution injectable subcutaneous
Norditropin SimpleXx 
Norditropin Simplex
Инжекционен разтвор в предварително напълнена писалка 
Solution for injection in pre-filled pen
51,Avenue J.F.Kennedy L-1855 
Pfizer Luxembourg SARL, 51 av. J.-F. Kennedy, 1855 Luxembourg
HUMATROPE 24 mg polvo y disolvente para solución inyectable 
HUMATROPE 24 mg polvo y disolvente para solución inyectable powder for solution Subcutaneous use
ES - Испания NOVO NORDISK A/SNovo 
ES - Spain NOVO NORDISK A/SNovo AlleBagsvaerdDK-2880
Humatrope 12 mg prašek in vehikel za raztopino 
Humatrope 12 mg prašek in vehikel za raztopino in injiciranje
NOVO NORDISK PHARMA SA Boulevard international 
NOVO NORDISK PHARMA SA
HUMATROPE 36 NE (12 mg) injekció patronban 
HUMATROPE 36 NE (12 mg) injekció patronban powder and solvent for injection
Genotropin 36 IU (12 mg) powder and solvent for solution for injection 
36 IU (12 mg) powder and solvent for solution for injection
RO - Румъния NOVO NORDISK A/S Novo Allé, DK-2880 
IT - Italy NOVO NORDISK A/S Novo Allé DK-2880
Humatrope 24 mg For Injection 
Humatrope 24mg For Injection powder for injection subcutaneous use
HUMATROPE 6 mg polvo y disolvente para solución inyectable 
HUMATROPE 6 mg polvo y disolvente para solución inyectable powder for solution Subcutaneous use
Eli Lilly & Co. Ltd. 
Eli Lilly ČR, s.r.o.
- Финландия Novo Nordisk A/S, Novo Allé, 2880 BAGSVAERD, 
FI - Finland Novo Nordisk A/S, Novo Allé, 2880 BAGSVAERD, Denmark
CY - Кипър NOVO NORDISK A/S, Novo Allé, DK-2880 
CY - Cyprus NOVO NORDISK A/S, Novo Allé, DK-2880 BAGSVAERD, DENMARK
HU - Унгария Pfizer Kft. 
Pfizer Kft.
5 mg/ 1,5 mg Инжекционен разтвор в предварително напълнена писалка 
5 mg/ 1,5 mg Solution for injection in pre-filled pen
in injiciranje 
Subcutanous injection
Швеция 
Denmark
HUMATROPE 12 mg polvo y disolvente para solución inyectable 
HUMATROPE 12 mg polvo y disolvente para solución inyectable powder for solution Subcutaneous use
Ferring GmbH, Wittland 11, D-24109 Kiel, 
Ferring GmbH,Wittland 11, D-24109 Kiel, Germany
Novo Nordisk A/S, Novo Allé, 2880 Bagsvaerd, 
Novo Nordisk A/S, Novo Allé, 2880 Bagsvaerd, Denmark
LT - Литва 
LTLithuania
NO - Норвегия NovoNordisk A/S, Novo Allé, 2880 Bagsværd, 
NovoNordisk A/S, Novo Allé, 2880 Bagsværd, Danmark
FR 
SC
Прах и разтворител за инфузионен разтвор 
powder for injection intramuscular and subcutaneous use
Интрамускулно и подкожно приложение 
Subcutaneous Intramuscular
ET - Естония Pfizer Enterprises SARL Round-Point du 
ET - Estonia Pfizer Enterprises SARL Round-Point du Kirchberg 51,Avenue J.F.Kennedy L-1855
NOVO NORDISK A/S Novo Allé DK-2880 Bagsvaerd 
Novo Nordisk A/S, Novo Allé DK-2880 Bagsværd, Denmark
Инжекционен разтвор в еднодозова опаковка 
Solution for injection Single dose container s.c.
PT - Португалия Novo Nordisk - Comércio de Produtos 
Novo Nordisk - Comércio de Produtos Farmacêuticos, Lda.
Norditropin Simplex 5 mg/1,5 ml solution for injection 
Norditropin SimpleXx 5 mg / 1,5 mL solution for injection injection
186 00 Praha 
20161 MILANO
Norditropin NordiFlex 10 mg/1.5 ml, solution for injection, in pre-filled pen 
Norditropin NordiFlex 10 mg/1.5 mL Solution for injection, prefilled syringe
Norditropin NordiFlex 5 mg/1.5 ml, solution for injection, in pre-filled pen 
Norditropin NordiFlex 5 mg/1,5 mlInjektionslösung in einem Fertigpen solution for injection, in pre-filled pen
10 mg/1,5 mL Инжекционен разтвор в предварително напълнена писалка 
10MG/1.5ML SOLUTION FOR INJECTION IN A PREFILLED PEN
Прах и разтворител за инжекционен разтвор в предварително напълнена спринцовка 
Powder and solvent for solution for injection in pre-filled syringe
15 mg/1,5 mL Инжекционен разтвор в предварително напълнена писалка 
15MG/1.5ML SOLUTION FOR INJECTION IN A PREFILLED PEN
10 MG/1,5 ML Инжекционен разтвор 
10MG/1.5ML SOLUTION FOR INJECTION
Norditropin NordiFlex 15 mg/1.5 ml, solution for injection, in pre-filled pen 
Norditropin NordiFlex 15 mg/1.5 mL Solution for injection, prefilled syringe
Инжекционен разтвор в предварително напълнена спринцовка 
solution for injection in pre-filled syringe
NORDITROPIN NORDIFLEX 5 mg / 1.5 ml solución inyectable 
Norditropin Nordiflex 5mg/1,5ml solution for injection subcutaneous
Norditropin SimpleXx 10 mg / 1.5 ml, solution for injection 
Norditropin SimpleXx 10 mg / 1,5 mL solution for injection injection
Norditropin Simplexx 15 mg/1,5 ml Injektionslösung 
Norditropin SimpleXx 15 mg/ 1,5 mL solution for injection injection
36 IU (12 mg) 
(12 mg)
Genotropin Miniquick 1,4 mg/0,25 ml Прах и разтворител за инжекционен разтвор 
Genotropin Miniquick 1.4 mg/0.25 ml Powder and solvent for solution for injection
Genotropin Miniquick 1,6 mg/0,25 ml Прах и разтворител за инжекционен разтвор 
Genotropin Miniquick 1.6 mg/0.25 ml Powder and solvent for solution for injection
Genotropin Miniquick 1,2 mg/0,25 ml Прах и разтворител за инжекционен разтвор 
Genotropin Miniquick 1.2 mg/0.25 ml Powder and solvent for solution for injection
Kirchberg 
LULuxembourg
BG - България Ferring GmbH, Wittland 11, D-24109 Kiel, 
LV - Latvia Ferring GmbH, Wittland 11, 24109 Kiel, Germany
Kiel 
sc
Norditropin FlexPro 10 mg/1,5 ml Injektionslösung in einem Fertigpen 
NORDITROPIN FlexPro 10 mg/1,5 ml solution for injection in pen
NORDITROPIN NORDIFLEX 15 mg/1,5 ml solución inyectable 
Norditropin Nordiflex 15mg/1,5ml solution for injection subcutaneous
Genotropin Miniquick 0,2 mg/0,25 ml Прах и разтворител за инжекционен разтвор 
Genotropin Miniquick 0.2 mg/0.25 ml Powder and solvent for solution for injection
NORDITROPIN NORDIFLEX 10 mg/1,5 ml solución inyectable 
Norditropin Nordiflex 10mg/1,5ml solution for injection subcutaneous
Humatrope 6 mg For Injection 
Humatrope 6mg For Injection powder for injection intramuscular and subcutaneous use
BG - България Novo Nordisk A/S, Novo Alle, DK-2880 
MT - Malta NovoNordisk A/S Novo Alle, DK - 2880
Този цикъл на лечение трябва да се повтаря на всеки 2 до 6 седмици. 
This cycle of treatment should be repeated every 2 to 6 weeks.
Допълнителна информация за Ivozall можете да намерите на уебсайта на Агенцията: ema.europa.eu/medicines/human/EPAR/ivozall. 
Further information on Ivozall can be found on the Agency's website: ema.europa.eu/medicines/human/EPAR/ivozall.
Прилага се като инфузия в продължение на 2 часа, всеки ден за период от пет дни. 
It is given by infusion lasting 2 hours every day for five days.
Лекарите трябва да преразгледат лечението при пациенти, чието състояние не се подобрява след един или два цикъла на лечение. 
Doctors should review treatment in patients whose condition does not improve after one or two treatment cycles.
Какви мерки се предприемат, за да се гарантира безопасната и ефективна употреба на Ivozall? 
What measures are being taken to ensure the safe and effective use of Ivozall?
Използва се, когато заболяването не се повлиява или се е проявило отново (рецидив) след прилагането на най-малко две други лечения и когато се очаква, че друго лечение няма да подейства. 
It is used when the disease has not responded to, or has come back (relapsed) after at least two other treatments and when no other treatment is expected to work.
Европейската агенция по лекарствата заключи, че в съответствие с изискванията на ЕС е доказано, че Ivozall е сравним с Evoltra. 
The European Medicines Agency concluded that, in accordance with EU requirements, Ivozall has been shown to be comparable to Evoltra.
За повече информация относно употребата на Ivozall вижте листовката или се свържете с вашия лекар или фармацевт. 
For more information about using Ivozall, see the package leaflet or contact your doctor or pharmacist.
То принадлежи към групата на противораковите лекарства, наричани „антиметаболити”. 
It belongs to the group of cancer medicines called ‘antimetabolites'.
Какви са ползите и рисковете, свързани с Ivozall? 
What are the benefits and risks of Ivozall?
Препоръчителната доза Ivozall се изчислява въз основа на ръста и теглото на пациента. 
The recommended dose of Ivozall is based on the patient's height and weight.
Това пречи на клетките да създават нова ДНК и РНК и да се делят, като по този начин се забавя растежа на туморните клетки. 
This stops the cells making new DNA and RNA and from dividing, thereby slowing down the growth of cancer cells.
Както за всяко лекарство, фирмата е предоставила проучвания за качеството на Ivozall. 
As for every medicine, the company provided studies on the quality of Ivozall.
Тъй като Ivozall е генерично лекарство, се приема, че ползите и рисковете са същите като при референтното лекарство. 
Because Ivozall is a generic medicine, its benefits and risks are taken as being the same as the reference medicine's.
Допълнителна информация за Ivozall: 
Other information about Ivozall
Проучвания за ползите и рисковете при одобрената употреба на активното вещество вече са проведени с референтното лекарство Evoltra и не е необходимо да се повтарят с Ivozall. 
Studies on the benefits and risks of the active substance in the authorised use have already been carried out with the reference medicine, Evoltra, and do not need to be repeated for Ivozall.
Както при всички лекарства, данните във връзка с употребата на Ivozall непрекъснато се проследяват. 
As for all medicines, data on the use of Ivozall are continuously monitored.
Не са необходими проучвания за „биоеквивалентност“, за да се изследва дали Ivozall се абсорбира подобно на референтното лекарство, така че да има същото ниво на активното вещество в кръвта. 
There was no need for ‘bioequivalence' studies to investigate whether Ivozall is absorbed similarly to the reference medicine to produce the same level of the active substance in the blood.
Лечението трябва да започне и да се следи от лекар с опит в лечението на пациенти с остра левкемия. 
Treatment should be started and supervised by a doctor who has experience in the management of patients with acute leukaemias.
Затова становището на Агенцията счита, че както при Evoltra, ползите от употребата на Ivozall превишават установените рискове и този продукт може да бъде разрешен за употреба в ЕС. 
Therefore, the Agency's view was that, as for Evoltra, the benefits of Ivozall outweigh the identified risks and it can be authorised for use in the EU.
Ivozall е противораково лекарство, което се използва за лечение на деца и възрастни до 21 години с остра лимфобластна левкемия (ОЛЛ), която представлява рак на лимфоцитите (вид бели кръвни клетки). 
Ivozall is a cancer medicine that is used to treat children and adults up to 21 years of age who have acute lymphoblastic leukaemia (ALL), a cancer of the lymphocytes (a type of white blood cell).
Защо Ivozall е разрешен за употреба в ЕС? 
Why is Ivozall authorised in the EU?
Съобщените нежелани реакции, свързани с употребата на Ivozall, внимателно се оценяват и се предприемат всички необходими мерки за защита на пациентите. 
Side effects reported with Ivozall are carefully evaluated and any necessary action taken to protect patients.
Препоръките и предпазните мерки за безопасната и ефективна употреба на Ivozall, които следва да се спазват от медицинските специалисти и пациентите, са включени в кратката характеристика на продукта и в листовката. 
Recommendations and precautions to be followed by healthcare professionals and patients for the safe and effective use of Ivozall have been included in the summary of product characteristics and the package leaflet.
Какво представлява Ivozall и за какво се използва? 
What is Ivozall and what is it used for?
Причината за това е, че Ivozall се прилага чрез инфузия във вена и активното вещество се доставя директно в кръвообращението. 
This is because Ivozall is given by infusion into a vein, so the active substance is delivered straight into the bloodstream.
Това означава, че Ivozall съдържа същото активно вещество и действа по същия начин като „референтното лекарство“, което вече е разрешено за употреба в ЕС и се нарича Evoltra. 
This means that Ivozall contains the same active substance and works in the same way as a ‘reference medicine' already authorised in the EU called Evoltra.
Общ преглед на Ivozall и основания за разрешаване в ЕС 
An overview of Ivozall and why it is authorised in the EU